MetaCap

Tenax Therapeutics Insider Trades

NASDAQ: TENXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.83-0.0277 (-1.49%)

Market open · Delayed 15 min · as of Oct 9, 2:43 PM ET

Last 12 months

Purchases
26 · $5.14M
Sales
0 · $0
Shares bought / sold
2.79M / 0
Net activity
Net buying $5.1 million

Tenax Therapeutics insider activity

Over the last 12 months, Tenax Therapeutics insiders reported 29 transactions on SEC Form 4: 26 open-market purchases and 0 sales. Insiders bought $5.1 million and sold $0 worth of stock, for net insider buying of $5.1 million. The most recent filing shows Doogan Declan (Director) buying 53,000 shares at $1.92 on Sep 16, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TENX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TENX insider transactions

Tenax Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 16, 2026Doogan DeclanDirectorBuy53,000$101.76KForm 4
Sep 15, 2026Giordano Christopher ThomasCEOBuy4,850$8.84KForm 4
Sep 11, 2026STAAB THOMAS R IIChief Financial OfficerBuy5,675$10.98KForm 4
Sep 11, 2026Giordano Christopher ThomasCEOBuy6,000$11.25KForm 4
Sep 3, 2026ADAR1 Capital Management, LLC & Schneeberger Daniel10% OwnerBuy900,000$1.60MForm 4
Sep 2, 2026ADAR1 Capital Management, LLC & Schneeberger Daniel10% OwnerBuy187,704$337.59KForm 4
Sep 1, 2026ADAR1 Capital Management, LLC & Schneeberger Daniel10% OwnerBuy179,058$321.57KForm 4
Aug 31, 2026ADAR1 Capital Management, LLC & Schneeberger Daniel10% OwnerBuy403,571$722.59KForm 4
Aug 24, 2026ADAR1 Capital Management, LLC & Schneeberger Daniel10% OwnerBuy107,374$188.36KForm 4
Aug 21, 2026ADAR1 Capital Management, LLC & Schneeberger Daniel10% OwnerBuy716,369$1.27MForm 4
Aug 20, 2026ADAR1 Capital Management, LLC & Schneeberger Daniel10% OwnerBuy202,124$359.54KForm 4
Jul 13, 2026Giordano Christopher ThomasCEOOption exercise8,500$50.49KForm 4
Jul 13, 2026Giordano Christopher ThomasCEOOption exercise219$777.23Form 4
May 11, 2026STAAB THOMAS R IIChief Financial OfficerAward10,000—Form 4
Dec 9, 2025Rich StuartChief Medical OfficerBuy2,500$25.54KForm 4
Dec 8, 2025Rich StuartChief Medical OfficerBuy2,500$25.25KForm 4
Dec 4, 2025Rich StuartChief Medical OfficerBuy2,500$23.00KForm 4
Dec 3, 2025Rich StuartChief Medical OfficerBuy1,500$13.62KForm 4
Dec 2, 2025Rich StuartChief Medical OfficerBuy1,000$9.01KForm 4
Nov 20, 2025Giordano Christopher ThomasCEOBuy538$4.08KForm 4
Nov 19, 2025Giordano Christopher ThomasCEOBuy455$3.42KForm 4
Nov 18, 2025Almenoff June SherieDirectorBuy1,900$14.28KForm 4
Nov 18, 2025Almenoff June SherieDirectorBuy1,900$14.28KForm 4
Nov 18, 2025Giordano Christopher ThomasCEOBuy1,612$12.50KForm 4
Nov 17, 2025Almenoff June SherieDirectorBuy93$664.95Form 4
Nov 17, 2025MCGAULEY THOMASInterim CFOBuy5,000$36.14KForm 4
Nov 17, 2025MCGAULEY THOMASInterim CFOBuy1,000$7.35KForm 4
Nov 17, 2025MCGAULEY THOMASInterim CFOBuy2,000$14.67KForm 4
Nov 17, 2025Almenoff June SherieDirectorBuy93$664.95Form 4
Aug 8, 2024Davidson Michael H.DirectorBuy2,500—Form 4
Aug 8, 2024PROEHL GERALD TDirectorBuy1,666—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related